Stocks
GlaxoSmithKline (GSK) OCF US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| OCF, £ | ? | 7 403 000 000 | 6 348 000 000 | 7 890 893 093 | 6 554 000 000 | 7 142 957 939 | 8 300 913 532 | ||
| Changes by years, y/y, % | 0% | -14% | +24% | -17% | +9% | -3.3% | |||
GlaxoSmithKline. OCF, £
GlaxoSmithKline. OCF, changes, %
GlaxoSmithKline. OCF, sum by quarters, £
GlaxoSmithKline (GSK) OCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| OCF, £ | ? | 1 145 000 000 | 2 096 000 000 | 3 027 580 859 | 2 036 332 673 | 1 141 000 000 | 8 300 913 532 | |
| Changes by years, y/y, % | +22% | +138% | +41% | -13% | 0% | |||
| Changes by quarters, q/q, % | -51% | +83% | +44% | -33% | -44% | |||
